KalVista Pharmaceuticals (KALV) Return on Sales Growth (1y) (2015 - 2025)

KalVista Pharmaceuticals (KALV) Return on Sales Growth (1y) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 KalVista Pharmaceuticals 1.36 Bn 1.36 Bn 49.41 Mn 7.00

Historic Data

Download Data
DateValue
Jul 31, 2025 7.00
Apr 30, 2020 2.00
Jan 31, 2020 -8.00
Oct 31, 2019 -2.00
Jul 31, 2019 -1.00
Apr 30, 2019 -3.00
Jan 31, 2019 0.00
Oct 31, 2018 5.00
Jul 31, 2018 60.00
Apr 30, 2018 44.00
Jan 31, 2018 31.00
Oct 31, 2017 15.00
Jul 31, 2017 -57.00
Mar 31, 2016 -204.00
Dec 31, 2015 -519.00
Sep 30, 2015 -397.00
Jun 30, 2015 -337.00
Mar 31, 2015 -497.00